$6 Billion U.S. Fertility Clinics Industry Hit Hard by Coronavirus

May 12, 2020:   Marketdata LLC, a leading independent market research publisher covering service markets since 1979, has released a new 145-page report entitled: U.S. Fertility Clinics & Infertility Services: An Industry Analysis .  This market study investigates demand for and the dollar value of: fertility clinics, sperm banks, egg donation, fertility drugs, and surrogacy programs.  It’s a loosely regulated but healthcare sector that grew strongly through 2019. The study estimates industry revenues from 1988 to 2025 Forecast. 
 
“The number of Assisted Reproductive Technology (ART) cycles performed by U.S. fertility clinics has been growing strongly  – estimated to total a record 331,00 IVF procedures last year. However, this year, domestic demand will suffer due to the recession and Covid-19 shut-downs, coupled with the projected lack of medical tourists from China and Europe.”, according to Research Director, John LaRosa.
 
 
Major Findings:
 

* Market Value…  Marketdata analysts estimate that the U.S. infertility services market will fall 18% -- from $6.0 billion to $4.8 billion this year. Unlike the Great Recession of 2008, which hardly impacted this business, the Coronavirus and recession will result in a much deeper slump. Marketdata analysts also don’t expect a strong rebound in 2021

 * The market is comprised of about 450 fertility clinics, 100+ sperm donor banks, the egg donors market, fertility drugs, and 1,700 reproductive endocrinologists – all competing for the business. ART / IVF procedures performed by fertility clinics are worth $3.3 billion of the total.

* This market is largely untapped, as 75% of potential clients are not using infertility services. Only 15% of U.S. women have used fertility drugs, only 5.5% have tried artificial insemination, and only 1% have used IVF. However, the number of IVF cycles performed has grown from 70,000 in 1997 to an estimated 331,000 in 2019.
 
* It’s safe to assume that the 150 hospital clinics were closed for two months beginning in mid-March.
An estimated 25% of the remaining 300 private clinics were closed as well, but not all. Some chose to remain open, while other closed. In most states, fertility clinics have been considered “essential” healthcare services, but not all – those in Massachusetts were closed.
 
* Chinese and European patients traveling to the U.S. for treatment have fueled much of the industry’s strong growth since 2014, an estimated 20-25% of the business, but their numbers have dwindled in 2020 and likely into 2021.
 
* The global market for fertility drugs is worth $1.1 billion, controlled largely by EMD Serono. The U.S. market is worth about $749 million, and is a mature market segment growing 6% annually. As IVF procedures’ success rates improve, less of these medications are needed.
 
* Studies indicate that up to 15% of couples of childbearing age of 20-44 in the United States are clinically infertile (about 15% of women and 10-15% of men).
 
* Only two “chains” of fertility clinics, IntegraMed and Prelude Fertility, exist, as most programs are small regional operations or are part of a hospital or University. Most are privately owned. IntegraMed operates some of the industry’s top fertility clinics—capturing 7-8% of market revenues.\
 
* During 2019 alone, investors have poured more than $150 million into start-ups like Modern Fertility and EverlyWell, which make at-home fertility-testing kits for women.
 
* The egg donor/frozen eggs market has been growing strongly, estimated to be worth $168 million this year, propped up by high demand from non-U.S. patients in Europe and the Middle East.
 
 
“Literally 50% of this industry’s clinics have shut down for two months so far in 2020, while the other half operates under new state mitigation restrictions and lesser patient volumes. The industry’s enviable growth record has been broken and is not likely to resume until 2022.”, according to Research Director, John LaRosa.

About The Report

U.S. Fertility Clinics & Infertility Services: An Industry Analysis , May, 2020, is an independently researched study that is 145 pages long, has 31 Tables, and costs $1,395. It is also sold by individual chapters. Free brochure and table of contents available. John LaRosa available for interviews. Contact: Marketdata LLC 7210 Wareham Drive, Tampa, FL  33647. (813-971-8080). Email: marketdataent@yahoo.com .  A 23 pp. Overview summary available for $99, at: www.marketdataenterprises.com.
 
About Marketdata LLC

Marketdata is a 40-year old market research and consulting firm, with a specialty analyzing a variety of service and healthcare sectors, and niche and emerging markets in the U.S. It performs custom research and consulting projects, as well as teleconferences. Its reports are available via several resellers (MarketResearch.com, Research and Markets), as well as online databases (Profound), wher clients purchase material by chapters or pages/sections.

Contact Information

John S. LaRosa

Research Director

Marketdata LLC

(1) 8139718080

marketdataent@yahoo.com